The authors found a statistically significant difference in the E/e’ ratio from the beginning to the third month of follow-up related to a reduction in myocardial velocity, while assessed by cells Doppler
The authors found a statistically significant difference in the E/e' ratio from the beginning to the third month of follow-up related to a reduction in myocardial velocity, while assessed by cells Doppler. cardiovascular therapy is an important prognostic factor in heart function recovery and to prevent heart failure development3. Thus, several biomarkers have been analyzed in an attempt at early detection of cardiotoxicity, particularly troponin, BNP and microRNAs4,5. However, the optimal time of collection, or an ideal population to be submitted to this screening is yet to be identified. In addition, more sensitive methods for the assessment of cardiac structure and function, such as magnetic resonance imaging and strain echocardiography seem to detect the subclinical forms of the disease2. Some medications generally used in the management of heart failure have…